Unknown

Dataset Information

0

Incorporating Tumor Characteristics to the American Joint Committee on Cancer Breast Cancer Staging System.


ABSTRACT: BACKGROUND:The American Joint Committee on Cancer (AJCC) breast cancer staging system provides important prognostic information. The recently published eighth edition incorporates biological markers and recommends the use of a complex "prognostic stage." In this study, we assessed the relationship between stage, breast cancer subtype, grade, and outcome in a large population-based cohort and evaluated a risk score system incorporating tumor characteristic to the AJCC anatomic staging system. MATERIALS AND METHODS:Patients diagnosed with primary breast cancer stage I-IV between 2005-2008 were identified in the California Cancer Registry. For patients with stage I-III disease, pathologic stage was recorded. For patients with stage IV disease, clinical stage was utilized. Five-year breast cancer specific survival (BCSS) and overall survival (OS) rates were determined for each potential tumor size-node involvement-metastases (TNM) combination according to breast cancer subtype. A risk score point-based system using grade, estrogen receptor, and human epidermal growth factor receptor 2 (HER2) status was designed to complement the anatomic AJCC staging system. Survival probabilities between groups were compared using log-rank test. Cox proportional hazards models were used. RESULTS:Among 43,938 patients, we observed differences in 5-year BCSS and OS for each TNM combination according to breast cancer subtype. The most favorable outcomes were seen for hormone receptor-positive tumors followed closely by HER2-positive tumors, with the worst outcomes observed for triple negative breast cancer. Our risk score system separated patients into four risk groups within each stage category (all p?

SUBMITTER: Chavez-MacGregor M 

PROVIDER: S-EPMC5679819 | biostudies-other | 2017 Nov

REPOSITORIES: biostudies-other

altmetric image

Publications

Incorporating Tumor Characteristics to the American Joint Committee on Cancer Breast Cancer Staging System.

Chavez-MacGregor Mariana M   Mittendorf Elizabeth A EA   Clarke Christina A CA   Lichtensztajn Daphne Y DY   Hunt Kelly K KK   Giordano Sharon H SH  

The oncologist 20170607 11


<h4>Background</h4>The American Joint Committee on Cancer (AJCC) breast cancer staging system provides important prognostic information. The recently published eighth edition incorporates biological markers and recommends the use of a complex "prognostic stage." In this study, we assessed the relationship between stage, breast cancer subtype, grade, and outcome in a large population-based cohort and evaluated a risk score system incorporating tumor characteristic to the AJCC anatomic staging sys  ...[more]

Similar Datasets

| S-EPMC7043951 | biostudies-literature
| S-EPMC4372850 | biostudies-other
| S-EPMC5710458 | biostudies-literature
| S-EPMC5978683 | biostudies-literature
| S-EPMC7682115 | biostudies-literature
| S-EPMC7492758 | biostudies-literature
| S-EPMC6342718 | biostudies-literature
| S-EPMC9356941 | biostudies-literature
| S-EPMC6509971 | biostudies-literature
| S-EPMC6583013 | biostudies-literature